Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Expanded_access × Waldenstrom Macroglobulinemia × zanubrutinib × Clear all

Status

No longer available 1

Sponsor Class

Study Type

Interventional 14 Observational 3 Expanded_access 1

Sponsor

Cancer Type

Conditions

Waldenstrom Macroglobulinemia 1 Recurrence 1

Interventions

zanubrutinib 1 pirtobrutinib 1 fludarabine phosphate 1 Whole-Body Irradiation 1 Tacrolimus 1 Mycophenolic Acid 1 Cytarabine 1 Cord Blood Stem Cell Transplantation 1 Busulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04052854 2024-10-23

A Single-Arm, Expanded Access Study of Zanubrutinib in Participants With B-cell Malignancies

BeiGene

No longer available

Waldenstrom Macroglobulinemia, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡